A detailed history of Capital Investment Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 5,878 shares of EW stock, worth $387,007. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,878
Previous 5,855 0.39%
Holding current value
$387,007
Previous $540,000 28.33%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$59.7 - $93.78 $1,373 - $2,156
23 Added 0.39%
5,878 $387,000
Q2 2024

Jul 12, 2024

SELL
$84.3 - $94.31 $843 - $943
-10 Reduced 0.17%
5,855 $540,000
Q1 2024

Apr 15, 2024

BUY
$72.54 - $95.56 $7,761 - $10,224
107 Added 1.86%
5,865 $560,000
Q4 2023

Jan 05, 2024

BUY
$61.71 - $77.76 $122,679 - $154,586
1,988 Added 52.73%
5,758 $439,000
Q3 2023

Oct 16, 2023

SELL
$69.28 - $93.38 $7,482 - $10,085
-108 Reduced 2.78%
3,770 $261,000
Q2 2023

Jul 11, 2023

BUY
$81.41 - $94.33 $315,707 - $365,811
3,878 New
3,878 $365,000
Q4 2022

Jan 05, 2023

BUY
$68.3 - $87.44 $39,818 - $50,977
583 Added 14.72%
4,543 $339,000
Q3 2022

Oct 05, 2022

SELL
$82.37 - $107.29 $13,920 - $18,132
-169 Reduced 4.09%
3,960 $327,000
Q2 2022

Jul 06, 2022

BUY
$86.5 - $128.27 $31,053 - $46,048
359 Added 9.52%
4,129 $393,000
Q1 2022

Apr 13, 2022

SELL
$101.96 - $128.34 $305 - $385
-3 Reduced 0.08%
3,770 $444,000
Q4 2021

Jan 10, 2022

SELL
$106.37 - $130.68 $23,188 - $28,488
-218 Reduced 5.46%
3,773 $489,000
Q3 2021

Oct 13, 2021

BUY
$102.91 - $122.75 $33,445 - $39,893
325 Added 8.87%
3,991 $452,000
Q2 2021

Jul 14, 2021

BUY
$83.84 - $104.76 $28,505 - $35,618
340 Added 10.22%
3,666 $380,000
Q1 2021

Apr 27, 2021

SELL
$78.68 - $90.67 $5,114 - $5,893
-65 Reduced 1.92%
3,326 $278,000
Q4 2020

Jan 21, 2021

SELL
$71.69 - $91.23 $23,872 - $30,379
-333 Reduced 8.94%
3,391 $309,000
Q3 2020

Oct 29, 2020

BUY
$67.19 - $87.44 $268 - $349
4 Added 0.11%
3,724 $297,000
Q2 2020

Jul 20, 2020

BUY
$57.54 - $76.95 $142,699 - $190,836
2,480 Added 200.0%
3,720 $257,000
Q1 2020

Apr 13, 2020

SELL
$52.41 - $81.0 $1,886 - $2,916
-36 Reduced 2.82%
1,240 $234,000
Q4 2019

Jan 21, 2020

SELL
$71.7 - $82.09 $6,524 - $7,470
-91 Reduced 6.66%
1,276 $298,000
Q3 2019

Oct 24, 2019

SELL
$61.55 - $75.43 $7,693 - $9,428
-125 Reduced 8.38%
1,367 $301,000
Q2 2019

Jul 17, 2019

SELL
$55.74 - $64.41 $2,229 - $2,576
-40 Reduced 2.61%
1,492 $276,000
Q1 2019

Apr 11, 2019

SELL
$47.89 - $64.05 $7,710 - $10,312
-161 Reduced 9.51%
1,532 $293,000
Q4 2018

Jan 17, 2019

BUY
$46.41 - $56.94 $78,572 - $96,399
1,693 New
1,693 $259,000
Q3 2018

Oct 15, 2018

SELL
$45.7 - $58.03 $87,287 - $110,837
-1,910 Closed
0 $0
Q2 2018

Jul 10, 2018

BUY
$42.45 - $51.3 $4,329 - $5,232
102 Added 5.64%
1,910 $278,000
Q1 2018

Apr 16, 2018

BUY
$37.19 - $47.45 $67,239 - $85,789
1,808 New
1,808 $252,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.